BMI-1 Expression Heterogeneity in Endometriosis-Related and Non-Endometriotic Ovarian Carcinoma

L Lozneanu, RA Balan, I Păvăleanu, SE Giuşcă… - International journal of …, 2021 - mdpi.com
BMI-1 is a key component of stem cells, which are essential for normal organ development
and cell phenotype maintenance. BMI-1 expression is deregulated in cancer, resulting in the …

Bmi-1 immunohistochemical expression in endometrial carcinoma is correlated with prognostic activity

K Horie, C Iseki, M Kikuchi, K Miyakawa, M Yoshizaki… - Medicina, 2020 - mdpi.com
Background and objectives: B-lymphoma Mo-MLV insertion region 1 (Bmi-1) is a stem cell
factor that is overexpressed in various human cancer tissues. It has been implicated in …

Immunohistochemical expression and prognostic relevance of Bmi-1, a stem cell factor, in epithelial ovarian cancer

HA El-Hadaad - Annals of diagnostic pathology, 2014 - Elsevier
Ovarian cancer is the fourth most common cause of cancer-related death in women. Bmi-1 is
a stem cell factor implicated in many human malignancies with poor outcome. Few …

BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor Corrigendum in/10.3892/or. 2022.8352

J Yu, L Chen, Z Bao, Y Liu, G Liu… - Oncology …, 2020 - spandidos-publications.com
Endometrial adenocarcinoma is one of the most common types of gynecological
malignancies and its incidence and mortality rates are increasing. Due to tumor recurrence …

Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma

GF Yang, WP He, MY Cai, LR He, JH Luo, HX Deng… - BMC cancer, 2010 - Springer
Background It has been suggested that the B-cell specific moloney leukemia virus insertion
site 1 (Bmi-1) gene plays an oncogenic role in several types of human cancer, but the status …

[引用][C] Can BMI-1 be a biomarker of poor prognosis?

K Itahana, GP Dimri - Epigenomics, 2010 - europepmc.org
This is a comment on" Bmi-1 is related to proliferation, survival and poor prognosis in
pancreatic cancer." Cancer Sci. 2010 Jul; 101 (7): 1754-60. This is a comment on" Intensive …

Role of BMI1 in epithelial ovarian cancer: investigated via the CRISPR/Cas9 system and RNA sequencing

Q Zhao, Q Qian, D Cao, J Yang, T Gui… - Journal of Ovarian …, 2018 - Springer
Background B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) might be
an appropriate biomarker in the management of epithelial ovarian cancer (EOC). However …

[PDF][PDF] Over-expression of BMI1 is associated with favorable prognosis in cervical cancer

BW Kim, H Cho, K Ylaya, JY Chung, SM Hewitt, JH Kim - 2016 - researchgate.net
Objective: B cell-specific Moloney murine leukemia virus integration site 1 (BMI1), is a
Plycomb group (PCG) protein, that is involved in the epithelial-mesenchymal transition …

Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis

X Zhang, CX Wang, C Zhu, J Zhang, S Kan… - International Journal of …, 2010 - ijgc.bmj.com
Introduction: B-cell-specific Moloney murine leukemia virus integration site 1 (Bmi-1) is a
member of polycomb group, which participates in axial patterning, hematopoiesis, cell cycle …

Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma

IB Engelsen, M Mannelqvist, IM Stefansson… - British journal of …, 2008 - nature.com
We studied the expression of polycomb group (PcG) protein BMI-1 in a large population-
based patient series of endometrial carcinomas in relation to clinical and molecular …